Similar articles

• [A new iron chelating agent: desferrioxamine B (Desferal). Clinico-pharmacological observations. Cases].

  Gallinelli R, Coppini D. Gallinelli R, et al. Minerva Med. 1965 Nov 17;56(92):3980-5. Minerva Med. 1965. PMID: 5845686 Italian. No abstract available.
• [Applications of a new chelating substance in ophthalmology. Therapeutic results in a case of ocular siderosis treated with desferrioxamine B].

  Valvo A, Del Duca A. Valvo A, et al. Ann Ottalmol Clin Ocul. 1965 Jul;91(7):497-513. Ann Ottalmol Clin Ocul. 1965. PMID: 5860342 Italian. No abstract available.
• [Effect of the ion-exchange resin desferrioxamine B on iron metabolism].

  Keler-Bacoka M, Hahn A. Keler-Bacoka M, et al. Lijec Vjesn. 1965 Dec;87(12):1329-38. Lijec Vjesn. 1965. PMID: 5880072 Serbian. No abstract available.
• The effect of interferon and desferrioxamine on serum ferritin and hepatic iron concentrations in chronic hepatitis B.

  Bayraktar Y, Saglam F, Temizer A, Uzunalimodlu B, van Thiel DH. Bayraktar Y, et al. Hepatogastroenterology. 1998 Nov-Dec;45(24):2322-7. Hepatogastroenterology. 1998. PMID: 9951916 Clinical Trial.
• Transfusion hemosiderosis. Report of a case treated with desferrioxamine-B.

  Kaung DT. Kaung DT. J Iowa Med Soc. 1965 Jun;55(6):312-6. J Iowa Med Soc. 1965. PMID: 5835475 No abstract available.